Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Environ Health Perspect. 2009 Jun;117(6):970-4. doi: 10.1289/ehp.0800440. Epub 2009 Feb 27.

Progression from beryllium exposure to chronic beryllium disease: an analytic model.

Author information

  • 1Division of Occupational and Environmental Medicine, Department of Family Medicine, University of California at Los Angeles, Los Angeles, California 90024, USA. pharber@mednet.ucla.edu

Abstract

BACKGROUND:

Understanding the progression from beryllium exposure (BeE) to chronic beryllium disease (CBD) is essential for optimizing screening and early intervention to prevent CBD.

METHODS:

We developed an analytic markov model of progression to cbd that assigns annual probabilities for progression through three states: from BeE to beryllium sensitization and then to CBD. We used calculations of the number in each state over time to assess which of several alternative progression models are most consistent with the limited available empirical data on prevalence and incidence. We estimated cost-effectiveness of screening considering both incremental (cost/case) and cumulative program costs.

RESULTS:

No combination of parameters for a simple model in which risk of progression remains constant over time can meet the empirical constraints of relatively frequent early cases and continuing development of new cases with long latencies. Modeling shows that the risk of progression is initially high and then declines over time. Also, it is likely that there are at least two populations that differ significantly in risk. The cost-effectiveness of repetitive screening declines over time, although new cases will still be found with long latencies. However, screening will be particularly cost-effective when applied to persons with long latencies who have not been previously screened.

CONCLUSIONS:

To optimize use of resources, the intensity of screening should decrease over time. Estimation of lifetime cumulative CBD risk should consider the declining risk of progression over time.

KEYWORDS:

beryllium; beryllium sensitization; chronic beryllium disease; cost-effectiveness; screening

PMID:
19590692
[PubMed - indexed for MEDLINE]
PMCID:
PMC2702415
Free PMC Article

Images from this publication.See all images (4)Free text

Figure 1
Figure 2
Figure 3
Figure 4
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for National Institute of Environmental Health Sciences Icon for PubMed Central
    Loading ...
    Write to the Help Desk